Eminence Organics
DECEMBER 24, 2024
Best Skin Care For A Dry Climate Written By (old): Thea Christie Do you live in an arid or desert climate and it's making your skin dry? If youve ever wondered what happens to our skin when there is a lack of humidity in the atmosphere, were here to explain. Whether you live in such an environment, or you notice skin changes when you travel, there are good reasons as to why your skin is acting up.
West Lake Dermatology
DECEMBER 24, 2024
Acne scars can linger long after active breakouts have healed, leaving many people feeling frustrated with their skins appearance. These scars come in various forms, from shallow depressions to deep, tethered scars that alter the skins texture. For those dealing with persistent acne scars, subcision has emerged as an effective treatment, particularly for more severe forms of acne scarring.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Texas Dermatology
DECEMBER 24, 2024
If youve already decided on laser hair removal and want to ensure the best results, understanding aftercare is essential. Laser hair removal works by safely targeting hair follicles with laser energy, destroying them to leave your skin smooth, supple, and hair-free. To help you maximize your results, Texas Dermatology is sharing the top 3 tips for effective laser hair removal aftercare.
The Dermatology Digest
DECEMBER 24, 2024
Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, reviews the latest efficacy and safety data on oral and topical Janus kinase (JAK) inhibitors used in dermatology. He spoke on this topic at the 2024 Revolutionizing Atopic Dermatitis (RAD) Conference. The post Important Updates on the Efficacy and Safety of JAK Inhibitors in Dermatology appeared first on The Dermatology Digest.
Dermatology Times
DECEMBER 24, 2024
James Song, MD, FAAD, discusses how recent advancements in atopic dermatitis treatment include targeted biologics and Janus kinase inhibitors that offer promising alternatives to traditional therapies for patients with moderate-to-severe disease.
Dermatology Times
DECEMBER 24, 2024
A panelist discusses how the current treatment options for atopic dermatitis range from topical corticosteroids and calcineurin inhibitors for mild cases to systemic medications such as dupilumab and Janus kinase inhibitors for moderate-to-severe disease, with selection based on factors such as disease severity, patient age, and safety considerations.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
DECEMBER 24, 2024
Dermatology Times is looking back on the top dermatology news headlines from 2024.
Dermatology Times
DECEMBER 24, 2024
Deucravacitinib achieved ACR20 response in PsA patients at Week 16, with a safety profile consistent with previous studies.
Expert insights. Personalized for you.
63 
Let's personalize your content